Neurodegenerative disease can progress in newly identified patterns

Researchers using machine learning find neurodegenerative disease progression can fall into newly identified patterns. The work, led by members of the MIT-IBM Watson AI Lab, may help predict patient prognoses, inform clinical trial designs, and discover underlying disease causes.

Related Keywords

United States ,Massachusetts ,Ernest Fraenkel ,Lou Gehrig ,Christinan Fournier ,Jamesd Berry ,Toddm Herrington ,Gradate Research Fellowship Program ,Natural History Consortium ,Department Of Defense ,Emory University School Of Medicine ,Ibm ,Microsoft Research ,United States Army Medical Research Acquisition Activity ,Watson Lab ,Principal Research Scientist Kenney Ng ,Muscular Dystrophy Association ,Clinical Trials Consortium ,Department Of Biological Engineering ,National Institutes Of Health ,Department Of Veterans Affairs Research ,Harvard Medical School ,Watson Ai Lab ,Research Scientist Soumya Ghosh ,Divya Ramamoorthy Phd ,Nature Computational ,Biological Engineering ,Kristen Severson Phd ,Karen Sachs Phd ,Next Generation Analytics ,Emory University School ,Pooled Resource Open Access ,Trials Consortium ,History Consortium ,Massachusetts General Hospital ,Veterans Affairs ,Research Fellowship Program ,Siebel Scholars Fellowship ,National Institutes ,Mit Ibm Watson Ai Laboratory ,Amyotrophic Lateral Sclerosis ,Als Progression ,Alzheimer Amp 039 S ,Arkinson Amp 039 S ,Ivya Ramamoorthy ,Soumya Ghosh ,Enney Ng ,Karen Sachs ,Nswer Als ,Machine Learning ,Ls Functional Rating Scale Revised Alsfrsr ,Eurological Disease Progression ,